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In the past 3-5 years cognitive impairment have been
reported in 15-50% of long-term infected and long-term
treated patients. Not full-blown HIV-dementia, but
more subtle memory problems and slowness, difficulties
in concentration, planning, and multitasking are the
characteristic complaints. Even in patients who are sys-
temically well-controlled these problems do occur.
So what is going on after so many years of apparently
controlled HIV-infection in the CNS? How severe is the
problem? Is it HIV-driven? Was HIV-infection well
under control in all patients without complaints or have
we missed ongoing replication in the brain? Has this
ongoing replication led to chronic immune-activation
and progressive damage to the brain? And what is the
role of co-morbidity in an HIV-infected population that
has entered their fifties and sixties. Do the “normal”,
non-HIV-related aging of the brain with vascular white
matter abnormalities cause additional damage to the
brain? Do we see cognitive problems, similar to the pat-
terns that we see in Alzheimer’s disease or sepsis where
inflammatory changes in the brain seem to play an
important role? Is the process of normal aging acceler-
ated in HIV-infection?
Chronic HIV-driven inflammation in an aging brain
could be the cause of what we see clinically today. It is
likely that HIV-replication in the brain is not the only
factor. Better CNS-penetrating drugs will not be the
only answer. Clinical characteristics, diagnostic tools
(new imaging techniques and CSF-analysis), course and
prognosis, possible interventions, antiretroviral and
adjunctive therapies will be discussed. The research
agenda for HIV-neurology is filled for the years ahead.
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